Impact Biomedical sets 1-for-12.62 reverse split ahead of merger
Impact Biomedical Inc. (NYSE American: IBO) has corrected a previously issued press release to fix an error in the merger ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

